Prevention Guidelines for Men 50-64

Alcohol misuse

All adults

At routine exams

Blood pressure

All adults

Every two years if your blood pressure reading is less than 120/80 mm Hg*

Yearly if your systolic blood pressure reading is 120 to 139 mm Hg or your diastolic blood pressure reading is 80 to 89 mm Hg*

Colorectal cancer

All adults

Check with your health care provider; fecal occult blood testing, sigmoidoscopy, and colonoscopy are the recommended screening methods

Depression

All adults with access to a clinical practice that has staff and systems in place to assure accurate diagnosis, effective treatment, and follow-up

At routine exams

Diabetes mellitus, type 2

Adults who are asymptomatic and have sustained blood pressure (treated or untreated) greater than 135/80 mm Hg

At routine exams

HIV

Anyone at increased risk for infection

At routine exams

Lipid disorders

All adults

At least every five years

Obesity

Anyone at increased risk

At routine exams

Syphilis

Anyone at increased risk for infection

At routine exams

Tuberculosis

Anyone at increased risk for infection

Check with your health care provider

Aspirin for primary prevention of cardiovascular events

Men ages 45 to 79 when potential benefits from a decrease in myocardial infarctions outweigh the harm or risks from an increase in gastrointestinal hemorrhage

When diagnosed with risk for cardiovascular/heart disease

Diet, behavioral counseling

Adults with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease

When diagnosed

Tobacco use and tobacco-related disease

All adults

Every visit

Tetanus/diphtheria/pertussis (Td/Tdap) booster

All adults

Td: Every 10 years

Tdap: Substitute a one-time dose of Tdap for a Td booster after age 18

Measles, mumps, rubella (MMR)

All adults ages 50 to 64 who lack prior infection or documented vaccinations**

One dose

Chickenpox (varicella)

Adults ages 50 to 64 who lack prior infection or documented vaccinations**

Two doses; second dose should be given 4 to 8 weeks after the first dose

Flu (seasonal)

All adults

Yearly during flu season

Hepatitis A

People at risk**

Two doses: For Havrix, at zero and 6 to 12 months; or for Vaqta, at zero and 6 to 18 months

Hepatitis B

People at risk**

Three doses; the second dose should be given 1 to 2 months after the first dose and the third dose given 6 months after the first dose

Meningococcal

People at risk**

One or more doses

Pneumococcal (polysaccharide)

People at risk**

One or more doses

Zoster

All men age 60 and older**

One dose